Terumo Corporation

Terumo Corporation

TRUMY
Terumo CorporationUS flagOther OTC
17.82
USD
-0.15
(-0.83%)
0.55EPS
32.40P/E
26.46BMarket Cap
Aug 06Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Mr. Hikaru Samejima
Full Time Employees
30,207
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
2-44-1, Hatagaya Tokyo Japan 151-0072
IPO Date
Jan 5, 2010
Similar Companies
Business
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

Company News

  • Terumo: Consistent Execution Continues To Drive Solid Growth Metrics

  • Terumo Corporation (TRUMF) Q4 2025 Earnings Call Transcript

  • Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System

  • Terumo Corporation (TRUMF) Q3 2025 Earnings Call Transcript

  • Terumo Corporation (TRUMF) Q2 2025 Earnings Call Transcript

  • Recent Price Trend in Terumo (TRUMY) is Your Friend, Here's Why

  • Terumo (TRUMY) Is a Great Choice for 'Trend' Investors, Here's Why

  • Here's Why Momentum in Terumo (TRUMY) Should Keep going

  • Are You Looking for a Top Momentum Pick? Why Terumo Corp. (TRUMY) is a Great Choice

  • What Makes Terumo (TRUMY) a New Buy Stock

  • Terumo (TRUMY) Unit Reveals WEB 17 Device Effective in Aneurysms

  • Terumo (TRUMY) Unit's SOFAST Study Shows Positive Results

  • Terumo Corporation (TRUMY) Q4 2024 Earnings Call Transcript

  • Terumo (TRUMY) Moves to Strong Buy: Rationale Behind the Upgrade

  • Best Momentum Stocks to Buy for March 28th

  • New Strong Buy Stocks for March 28th

  • What Makes Terumo Corp. (TRUMY) a Good Fit for 'Trend Investing'

  • Terumo Corp. (TRUMY) is on the Move, Here's Why the Trend Could be Sustainable

  • Terumo Corporation (TRUMF) Q3 2024 Earnings Call Transcript

  • Terumo Corp. (TRUMY) is on the Move, Here's Why the Trend Could be Sustainable